Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure

CKD-330 Drug-Drug Interaction Study (Candesartan)

NCT02064621 ·Status: COMPLETED ·Phase: PHASE1

A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia

NCT00171093 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D958 in Healthy Adults

NCT05921435 ·Status: COMPLETED ·Phase: PHASE1

A Trial of Fimasartan for Early Diastolic Heart Failure

NCT01691118 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension

NCT01289132 ·Status: COMPLETED ·Phase: PHASE2

Effect of Fully Blocking Type 1 Angiotensin Receptor on Target Organ Damage of Postmenopausal Hypertensive Women

NCT03432468 ·Status: UNKNOWN ·Phase: NA

Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)

NCT00348686 ·Status: COMPLETED ·Phase: PHASE4

Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects

NCT05571813 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012

NCT04035538 ·Status: UNKNOWN ·Phase: PHASE1

A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People

NCT01259297 ·Status: TERMINATED ·Phase: PHASE3

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy

NCT05526703 ·Status: UNKNOWN ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

NCT05359068 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome

NCT00409578 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure

NCT00853658 ·Status: COMPLETED ·Phase: PHASE3

Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.

NCT01541189 ·Status: COMPLETED ·Phase: PHASE4

The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure

NCT00241098 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy

NCT05878561 ·Status: COMPLETED ·Phase: PHASE3

Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg

NCT00383929 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension

NCT01413048 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction

NCT02884206 ·Status: COMPLETED ·Phase: PHASE3

Candesartan Effect in Second Stage Arterial Hypertension

NCT00621153 ·Status: COMPLETED ·Phase: PHASE4

A Pharmacogenomic Study of Candesartan in Heart Failure

NCT00400582 ·Status: COMPLETED ·Phase: PHASE4

A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension

NCT02059616 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin

NCT00385931 ·Status: COMPLETED ·Phase: PHASE3

The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension

NCT01135212 ·Status: COMPLETED ·Phase: PHASE3